Neuroscientists use innovative gene therapy technique to blaze new trails in neurological disorders research.
It's not surprising that neuroscientists in the School of Medicine are conducting research on epilepsy, Alzheimer's disease, neuropathic pain, cognition, mood disorders, and other nervous system-related conditions.
But it is extraordinary that all of them are using a similar gene therapy technique to blaze new trails of discovery. It's a technique made possible by a laboratory at the School of Medicine that engineers the key ingredients for gene therapy research used by neuroscientists around the world.
We've had these viral-vector lab facilities for a quite a while, and [lab director] Steve Wilson is recognized as one of the international leaders in developing this technology as a tool for neuroscience research," said Marlene Wilson, Ph.D. (no relation to Steve Wilson), a professor and interim chair of the Department of Pharmacology, Physiology, and Neuroscience.
Wilson and her colleagues all use common viruses that have been altered in special ways to deliver genetic instructions to a specific target—either in the brain or the peripheral nervous system. The designer viruses are harmless but effective messengers of genetic material.
The gene transfer technique is allowing the neuroscientists to better understand the biochemical mechanisms associated with certain disorders and diseases. In some instances, they might be able to develop better targets for medications; in other cases, the gene therapy itself might introduce new ways of treating disease.
Here's a closer look at their research:
With practicing physicians who also teach at the University of South Carolina School of Medicine, University Specialty Clinics® represents a partnership between academic medicine, community hospitals, healthcare organizations and private clinicians.
One, Two, Three, Four, Seven, Nine, Fourteen and Fifteen Medical Park